Literature DB >> 17824257

Patients' views on optimal visit length in primary care.

Dan-Avi Landau1, Yaacov G Bachner, Keren Elishkewitz, Liav Goldstein, Erez Barneboim.   

Abstract

Visit length (VL) has been decreasing over the last decades. Patients and physicians alike hold that this may have adverse affects on quality of care and patient-doctor rapport. Our aim was to study the optimal VL as viewed by the patients as well as possible related factors such as demographicparameters and patient satisfaction. By using surveys, we determined that patient satisfaction was highly correlated with VL and satisfaction from VL. Optimal VL as viewed by the patients was 15.4 minutes on average with considerable variation. Longer expected VL was associated with longer visits. Patient satisfaction from the visit was significantly decreased when expressed optimal VL exceeded the estimated duration of the visit. The surveys demonstrated that in young adults, satisfaction is highly correlated with VL. When asked, patients expect attainable VLs, which are on average only somewhat longer then the scheduled duration. We believe that patients should take part in decisions regarding visit scheduling. We suggest that individualization may contribute to the cost-effectiveness of physicians' time.

Entities:  

Mesh:

Year:  2007        PMID: 17824257

Source DB:  PubMed          Journal:  J Med Pract Manage        ISSN: 8755-0229


  3 in total

1.  Secondary Use of Electronic Health Record Data for Prediction of Outpatient Visit Length in Ophthalmology Clinics.

Authors:  Wei-Chun Lin; Isaac H Goldstein; Michelle R Hribar; Abigail Huang; Michael F Chiang
Journal:  AMIA Annu Symp Proc       Date:  2018-12-05

2.  Observational study to determine predictors of rheumatology clinic visit provider contact time.

Authors:  Lisa A Davis; Molly M Larson; Liron Caplan
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-06-25       Impact factor: 4.794

3.  Improving communication in the primary care setting: perspectives of patients with speech disabilities.

Authors:  Megan A Morris; Kathryn Yorkston; Marla L Clayman
Journal:  Patient       Date:  2014       Impact factor: 3.883

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.